Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
Biogen chalks up a Tecfidera patent win in Europe after losing US protections
After FDA rejection, Gilead nears full EU nod for hep D drug
Judge orders J&J, talc opponents to engage in settlement talks
*please scroll down for all the latest news*
